JB

Jasper Bos

General Partner at Forbion

Amsterdam, North Holland

Overview

Work Experience

e

enGene

  • Board Member

    2023 - Current

AA

ANAVEON AG

  • Board Member

    2022

F

Forbion

  • General Partner

    2021

  • Forbion European Acquisition Corporation (NASDAQ: FRBN) Chief Executive Officer

    2021 - 2023

MV

M Ventures

  • Senior Vice President & Managing Director

    2019 - 2021

  • Vice President, Head of Healthcare Fund M Ventures

    2016 - 2019

ML

Metabomed Ltd.

  • Member of the Board of Directors

    2016 - 2021

GI

Galecto, Inc.

  • Member of the Board of Directors

    2012 - 2019

Calypso biotech SA

  • Chairman Of The Board Of Directors

    2013 - 2019

Prexton Therapeutics SA

  • Board Member

    2012 - 2018

Neviah Genomics

  • Board Member

    2012 - 2016

MS

Merck Serono

  • Senior Director MS Ventures

    2014 - 2016

  • Director Merck Serono Ventures

    2011 - 2014

  • Associate Director Merck Serono Ventures

    2009 - 2011

Education

Investments

Engrail Therapeutics

Series B

Total Funding: $220M

Precirix

Series B

Total Funding: $130M

Anaveon

Series B

Total Funding: $160M

Inthera Bioscience

Seed

Total Funding: $20M

Relevant Websites